Glenmark gains on becoming first company in India to launch Teneligliptin + Dapagliflozin Fixed Dose Combination
Glenmark Pharmaceuticals is currently trading at Rs. 398.00, up by 2.60 points or 0.66% from its previous closing of Rs. 395.40 on the BSE. The scrip opened at Rs. 396.60 and has touched a high and low of Rs. 403.00 and Rs. 392.65 respectively. So far 21781 shares were traded on the counter. The BSE … Read more
